you are all idiots and dont know anything. The stock is going above 300. The NASH trial already succeeded with sicker diabetic patients. They stopped it early because of huge success. Enrolling better patients in stage 1 2 3 fibrosis it will not only reverse fibrosis but also achieve nash resolution. Liver transplants cost million dollars. They will price the drug at 50k/yr and that is easily 6 billion dollars revenues just for pbc alone. No need to sell the company. plus int 767 is even more potent. When you remove the fat from the liver LDL is bound to go up and will need to be treated with statins.